Blog, Opinion

True Innovation Requires R&D Without Borders

Imagine a world where an MRI scan doesn’t cost a fortune, where a small rural hospital can diagnose illness with the same precision as a world-class medical center. This isn’t futuristic thinking, it’s already taking shape in labs and startups across the Global South. Affordable MRI machines like those from Voxelgrids are proving that innovation doesn’t have to be expensive or out-of-reach to be extraordinary.

randd

The biggest problems of our time - climate change, global health, rising inequality - don’t need passports. They’re borderless, messy, and pose wicked challenges for all of us. They won’t be solved by baby steps or business as usual. What they really need is reimagined research & development (R&D). When bright minds across borders collaborate, breakthroughs become accessible, not exclusive. Science and philanthropy, working hand in hand, can turn once-unthinkable ideas into public goods that serve everyone. Because innovation is everywhere, it’s a shared resource, and a global knowledge bank that we can all build on, together. 

There’s both a moral and a practical reason for deeper R&D partnerships between the Global North and South. The North has deep pockets, strong regulation, and tried-and-tested infrastructure. The South has something money can’t buy - on-the-ground insight, cost-effective testing grounds, fresh talent, and problems that need acute solving. Put the two together and you get faster, cheaper, and smarter innovation. You get solutions that travel well and work where they land.

We’ve seen this magic happen before. During COVID-19, North-South collaboration in R&D showed us science in action. The North tackled early research and regulatory hurdles, while scientists from the South contributed to clinical trials, field data, and ingenious delivery systems. And when it was time to actually make the vaccines, countries like India, South Africa, and Brazil stepped up as the world’s factories. The result? A global breakthrough that arrived faster than any one region could have managed alone.

Turns out, when it comes to innovation, the world’s best lab is the one without borders.

Translational Research as an Opportunity for Global Collaboration

The 2025 Nobel Prize in Economics is a perfect illustration of the global nature of knowledge and its potential for shared prosperity. Dr Joel Mokyr emphasizes the concept of “propositional knowledge” - the knowhow behind the why of things - and “prescriptive knowledge”, the practical application of theory.

However, this idea faces the notorious ‘Valley of Death’, the chasm between a promising laboratory discovery and full commercial deployment at scale. This gap is where countless high-impact solutions for social good falter.  Collaborative models where expertise, infrastructure, and capital are pooled, can accelerate the journey from discovery to deployment, particularly for innovations addressing health, climate, and sustainability.

Social Alpha: A Model for Derisking and Deployment

Successfully navigating the ‘Valley of Death’ requires a specialized, hands-on approach. One organization that has managed this journey is Social Alpha, a venture philanthropy platform for science and technology-based social enterprises in India. Social Alpha takes a “full-stack” model, structured around three core pillars: 

  1. Develop: 

    Access to labs, infrastructure and technical support to high-potential scientific breakthroughs, to help build prototypes of solutions

  2. Derisk: 

    Catalytic, risk-tolerant capital (grants and seed funding) that traditional investors will not support to help test prototypes in the market. 

  3. Deploy: 

    Validated solutions are connected - through Social Alpha’s network - with impact capital and market access partners to help them scale their impact. 


This ‘develop-derisk-deploy’ pipeline is a high-support conveyor belt across the infamous valley of death, proving that with the right mix of patient capital and expert support, deep-tech innovations can solve our most entrenched social problems.

This approach has led to successful innovations such as Voxelgrid’s affordable MRI machines transforming the access to diagnostics, Rechargion’s sodium-ion batteries supporting clean energy transition and Tan90’s cold storage solutions reducing post-harvest losses, thereby increasing remuneration for smallholder farmers.
 

fasalamrit
From lab to field: A community demonstration of Fasal Amrit brings scientific innovation to the hands of smallholder farmers, turning waste into water security.


Case Study: From Waste to Water Security 

How EF Polymer is Turning Science into Soil Resilience

The Challenge

Climate change is making rainfall erratic and water scarce, hitting smallholder farmers the hardest. Traditional farming practices - heavy on irrigation and chemical inputs - are degrading soil and undermining long-term resilience.

The Opportunity

Social Alpha saw the potential for deep science to solve these root challenges. Technology interventions could reduce water stress, rebuild soil health, and enhance farmer incomes, all while driving sustainable growth.

The Solution - from Lab to Market

EF Polymer developed Fasal Amrit, a natural, super-absorbent polymer made by upcycling fruit and vegetable waste. The innovation helps soil retain moisture and nutrients, reducing irrigation needs by up to 40% and fertilizer use by 20%. Through Social Alpha’s India Agritech Incubation Network (IAIN), EF Polymer received scientific validation, incubation, and market readiness support. The company has since scaled to reach over 40.000 farmers and has raised a 17.8 million dollar Series-B round for global expansion.

Impact and Scale

The company has a commercial presence in 13 countries, and the innovation has been featured on Forbes Asia’s “100 to Watch” (2024) list.

Key Takeaway

By turning biodegradable waste into water security, EF Polymer shows how cross-sector collaboration - from lab scientists to local farmers - can transform deep science into lasting social impact.

 

ITRI: Building the National Infrastructure for Translation

While Social Alpha provides the "venture" support, scaling translational research requires a systemic, national-level infrastructure. Enter India's Translational Research Initiative (ITRI), a nation-wide, collaborative philanthropic initiative designed to catalyze innovation by building the missing infrastructure to bridge the lab-to-market gap.


ITRI's model operates on the understanding that individual academic institutions, however brilliant, often lack the dedicated resources, industry connections, and ‘translational’ talent to move research from the labs into people’s hands. ITRI's solution is to create a network of Translational Research Centres (TRCs) embedded within India's premier research institutions. The centres cater to developing solutions for endemics like cancer and diabetes, precision medicine, mitigating heat stress, and other critical technology areas. These TRCs are funded through a collaborative model that brings philanthropy, industry partners, and government together.

ITRI's stakeholders are a coalition for impact: academia provides the foundational science, philanthropy provides the risk-tolerant capital, and industry provides the pathway to scale and real-world validation. ITRI’s recent MoU with the UK's Centre for Process Innovation (CPI), focusing on biomanufacturing, sustainable materials and other technology areas, is a perfect illustration of North-South collaboration to solve shared global problems.

 

voxelgrids
Redefining access: Voxelgrids’ affordable MRI machines bring world-class diagnostic imaging within reach of small hospitals and rural healthcare centers.

 

The Case for a Collaborative Future

Imagine the vast possibilities when R&D-based solutions are directed towards accessible social good.  Here's what cross-sector leadership towards realizing this vision could look like:

  • Corporates: For companies, the opportunity lies beyond traditional CSR, when social value becomes part of the innovation engine itself. Imagine R&D pipelines that design for low-resource environments, or partnerships that bring breakthrough technologies to new markets. Corporates can co-fund translational research platforms like ITRI, collaborate with incubators and social enterprises, and pilot credit-based collaboration models.
     
  • Philanthropy: Philanthropy can be the bridge between science and scale. By backing early-stage, high-impact research and supporting open translational infrastructure, funders can help promising ideas find their footing. Investing in digital platforms that connect researchers, labs, and technologies across geographies would make expertise more discoverable and collaboration faster, thereby turning . ideas into real-world outcomes.
     
  • Researchers and academic institutions: For researchers, collaboration is no longer a nice-to-have; it’s the future of discovery. North-South partnerships, shared fellowships, and open data exchange platforms can help ideas cross borders and disciplines. Collaboration is also about amplification. When institutions pool expertise and context, innovation becomes both globally relevant and locally grounded.

The world doesn’t need another patchwork of innovation silos. It needs an ecosystem that’s connected, inclusive, and driven as much by purpose as by profit. The payoff is obvious: faster breakthroughs, smarter spending, and solutions that work for more people, not just more markets. The real question is, can we stop admiring the opportunity long enough to actually grab it? Therein lies the solution to true, borderless innovation.